Newsroom
  • August 19 , 2020

    Study finds cancer-boosting culprit that multiplies with age

    As our bodies convert food into energy, they produce debris that accumulates as we age. New research shows that one of these metabolic throwaways plays a potentially deadly role in the development of cancer.
    Read more
  • August 18 , 2020

    Acidic niche keeps lymphatic system in check during immune response

    In the fight against cancer, the immune system is the first line of defense. The lymphatic system specifically is essential to protecting the body against foreign invaders. Activation of immune cells in the lymph nodes leads to the production and release of antibodies, and activation of lymphocytes, including T cells, to battle infection. But little is known
    Read more
  • August 17 , 2020

    Potency-enhancing drugs linked to decreased risks in men with colorectal cancer

    A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Commu
    Read more
  • August 16 , 2020

    Evidence reviews support avoiding opioid prescriptions for sprains and strains

    Two new evidence reviews related to acute musculoskeletal injuries like strains and sprains suggest other forms of treatments are as effective as opioids and have less risk of harms to patients.
    Read more
  • August 14 , 2020

    Probe detects the destruction of defective mitochondria

    A versatile probe that can detect with pinpoint accuracy the programmed destruction of defective mitochondria—the powerhouses of cells—has been developed by RIKEN researchers. They used it to show that damaged mitochondria in dopamine-producing neurons fail to be destroyed in mice with a condition resembling Parkinson's disease.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us